Author： Hawkins David Huston Sally A
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.8, 2006-06, pp. : 989-1003
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Pharmacoeconomic considerations with statin therapy
By Speidel Katie M Hilleman Daniel E
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. :
Pharmacoeconomic Considerations in Treating Actinic Keratosis
PharmacoEconomics, Vol. 27, Iss. 6, 2009-06 ,pp. :
Pharmacoeconomic Considerations in Treating Ovarian Cancer
By Bodurka-Bevers D. Sun C.C. Gershenson D.M.
PharmacoEconomics, Vol. 17, Iss. 2, 2000-02 ,pp. :
Pharmacoeconomic Considerations in the Treatment of Multiple Sclerosis
By Sharac Jessica McCrone Paul Sabes-Figuera Ramon
Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. :